Meta-analysis of mNGF therapy for peripheral nerve
【Abstract】Objective: To assess the efficacy and safety of mouse nerve growth factor (mNGF) in patients with peripheral nerve injury. Methods: Such electronic database as Cochrane Li-brary (Issue 1, 2011), Medline (1950-2011), Embase (1980-2011), National Knowledge Infrastructure (1979-2011)...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-04-01
|
Series: | Chinese Journal of Traumatology |
Online Access: | http://www.cjtrauma.com/apps/ojs/index.php/cjt/article/view/205 |
id |
doaj-f99194c028914c6e9f9e133b48e20dc9 |
---|---|
record_format |
Article |
spelling |
doaj-f99194c028914c6e9f9e133b48e20dc92020-11-24T22:53:29ZengElsevierChinese Journal of Traumatology1008-12752012-04-011528691126Meta-analysis of mNGF therapy for peripheral nerveLIU Yan-rongLIU Qiang【Abstract】Objective: To assess the efficacy and safety of mouse nerve growth factor (mNGF) in patients with peripheral nerve injury. Methods: Such electronic database as Cochrane Li-brary (Issue 1, 2011), Medline (1950-2011), Embase (1980-2011), National Knowledge Infrastructure (1979-2011) were searched and meanwhile relevant journals such as Chinese Journal of Orthopaedics, Chinese Journal of Microsurgery, Chinese Journal of Neurosurgery, etc were searched as well to collect all randomized controlled trials and quasi-randomi-zed controlled trials of mNGF on patients with peripheral nerve injury. The quality of included studies was assessed according to the criteria recommended by the Cochrane Handbook for Systematic Reviews of Interventions and the data were extracted by two reviewers independently. Meta-analysis was conducted by RevMan 5.1 software. Results: Forty-one studies involving 3 304 patients with peripheral nerve injury were included. The results of meta-analysis showed that: (1) the total effective rate of peripheral nerve injury treatment in mNGF group was ob-viously higher than that in control group (OR=6.36, 95% CI 4.96-8.15, P<0.01); (2) the scores of activities of daily living (ADL) in mNGF group was significantly higher than that in control group (weighted mean difference=1.97, 95% CI 1.33-2.61, P<0.01); (3) the incidence of adverse reaction in mNGF group was higher than that in control group, (OR=1.66, 95% CI 1.61-2.38, P=0.006), but the adverse effects were mild, which could be relieved without specific treatment or just given symptomatic treatment, and disappeared at the end of treatment. Conclusions: The mNGF therapy is effective for pe-ripheral nerve injury. It can obviously improve patient’s ADL. Though the incidence of adverse reaction in mNGF treatment group is higher than that in control group, this does not influence the treatment outcomes. Key words: Peripheral nerves; Nerve growth factor; Randomized controlled trial; Meta-analysishttp://www.cjtrauma.com/apps/ojs/index.php/cjt/article/view/205 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
LIU Yan-rong LIU Qiang |
spellingShingle |
LIU Yan-rong LIU Qiang Meta-analysis of mNGF therapy for peripheral nerve Chinese Journal of Traumatology |
author_facet |
LIU Yan-rong LIU Qiang |
author_sort |
LIU Yan-rong |
title |
Meta-analysis of mNGF therapy for peripheral nerve |
title_short |
Meta-analysis of mNGF therapy for peripheral nerve |
title_full |
Meta-analysis of mNGF therapy for peripheral nerve |
title_fullStr |
Meta-analysis of mNGF therapy for peripheral nerve |
title_full_unstemmed |
Meta-analysis of mNGF therapy for peripheral nerve |
title_sort |
meta-analysis of mngf therapy for peripheral nerve |
publisher |
Elsevier |
series |
Chinese Journal of Traumatology |
issn |
1008-1275 |
publishDate |
2012-04-01 |
description |
【Abstract】Objective: To assess the efficacy and
safety of mouse nerve growth factor (mNGF) in patients
with peripheral nerve injury.
Methods: Such electronic database as Cochrane Li-brary (Issue 1, 2011), Medline (1950-2011), Embase (1980-2011), National Knowledge Infrastructure (1979-2011) were
searched and meanwhile relevant journals such as Chinese
Journal of Orthopaedics, Chinese Journal of Microsurgery,
Chinese Journal of Neurosurgery, etc were searched as well
to collect all randomized controlled trials and quasi-randomi-zed controlled trials of mNGF on patients with peripheral
nerve injury. The quality of included studies was assessed
according to the criteria recommended by the Cochrane
Handbook for Systematic Reviews of Interventions and the
data were extracted by two reviewers independently. Meta-analysis was conducted by RevMan 5.1 software.
Results: Forty-one studies involving 3 304 patients
with peripheral nerve injury were included. The results of
meta-analysis showed that: (1) the total effective rate of
peripheral nerve injury treatment in mNGF group was ob-viously higher than that in control group (OR=6.36, 95% CI
4.96-8.15, P<0.01); (2) the scores of activities of daily living
(ADL) in mNGF group was significantly higher than that in
control group (weighted mean difference=1.97, 95% CI
1.33-2.61, P<0.01); (3) the incidence of adverse reaction in
mNGF group was higher than that in control group, (OR=1.66,
95% CI 1.61-2.38, P=0.006), but the adverse effects were
mild, which could be relieved without specific treatment or
just given symptomatic treatment, and disappeared at the
end of treatment.
Conclusions: The mNGF therapy is effective for pe-ripheral nerve injury. It can obviously improve patient’s
ADL. Though the incidence of adverse reaction in mNGF
treatment group is higher than that in control group, this
does not influence the treatment outcomes.
Key words: Peripheral nerves; Nerve growth factor;
Randomized controlled trial; Meta-analysis |
url |
http://www.cjtrauma.com/apps/ojs/index.php/cjt/article/view/205 |
work_keys_str_mv |
AT liuyanrong metaanalysisofmngftherapyforperipheralnerve AT liuqiang metaanalysisofmngftherapyforperipheralnerve |
_version_ |
1725663244862881792 |